Peptide purity is the single most important quality metric when evaluating research compounds. Understanding what peptide purity means, how it is measured, and how to read a Certificate of Analysis (COA) can be the difference between reliable experimental data and confounded results. This comprehensive guide covers everything researchers need to know about peptide purity standards and COA evaluation.
A Certificate of Analysis is the only objective evidence that what is on the label matches what is in the vial. Yet most buyers never read one — and many vendors count on that.
After the Peptide Sciences shutdown, Paradigm Peptides’ federal charges (products contained testosterone instead of the labeled compounds), and FDA enforcement actions across the industry, the ability to evaluate a COA is no longer optional for serious researchers. This guide explains what peptide purity means, how it is measured, and exactly how to read a COA to verify what you are buying.
What “Peptide Purity” Actually Means in Research
Peptide purity refers to the percentage of the total sample that consists of the target compound versus impurities. A product sold at 99% purity means that 99% of the material in the vial is the intended peptide, and 1% consists of other substances — synthesis byproducts, degradation products, residual solvents, or truncated sequences.
The remaining impurities matter because they can interfere with experimental results (confounding variables), cause unexpected biological effects (off-target activity), or indicate poor manufacturing quality (suggesting potential issues with identity, stability, or sterility). Researchers working with low-purity samples may observe inconsistent dose-response curves, failed replication, or unexpected biological effects that are actually caused by contaminants rather than the target compound itself.
Why 99%+ Is the Research Standard
Different purity grades serve different purposes in laboratory research:
| Purity Range | Typical Use | Impurity Level |
|---|---|---|
| 99%+ | Research grade — standard for published research and serious experimental work | Less than 1% |
| 95-98% | General laboratory use — acceptable for some applications but introduces more variables | 2-5% |
| Below 95% | Not suitable for most research — significant impurity burden | 5%+ unknown substances |
For context: a 5mg vial at 90% purity contains only 4.5mg of actual compound plus 0.5mg of unknown impurities. At 99%+ peptide purity, the same vial contains 4.95mg of target peptide with less than 0.05mg of impurities — a 10x reduction in unknowns. This difference is especially critical in receptor-binding assays and cell-based research where impurities can activate competing pathways and corrupt dose-response data.
The Two Essential Tests That Determine Peptide Purity
HPLC (High-Performance Liquid Chromatography)
HPLC answers the question: “How pure is it?”
The technique separates a sample into its individual components by passing it through a column under high pressure. Each component exits the column at a different time (retention time) and is detected by UV absorption at 220nm — the wavelength at which peptide bonds absorb light. The result is a chromatogram showing peaks for each component, with the area under each peak proportional to the amount of that substance.
On a good HPLC chromatogram confirming high peptide purity, researchers will see one dominant peak (the target compound) and minimal smaller peaks (impurities). The purity percentage is calculated as the area of the main peak divided by the total area of all peaks. A 2007 review published in the Journal of Chromatography B established reversed-phase HPLC as the gold standard for purity analysis, noting that it can resolve impurities that differ by as little as a single amino acid substitution.
What to look for on a COA:
- Purity percentage: Should be 99%+ for research-grade compounds
- Method details: Column type, mobile phase, and detection wavelength should be specified — this allows the test to be reproduced
- Retention time: Should match the expected retention time for the target compound under the specified conditions
Mass Spectrometry (MS) — Confirming Identity
Mass Spectrometry answers the question: “Is this the right compound?”
HPLC tells you something is 99% pure — but it does not tell you what that “something” is. Mass Spectrometry measures the molecular weight of the compound and compares it to the known molecular weight of the target peptide. If the observed mass matches the expected mass (within instrument tolerance, typically ±1 Da), the compound’s identity is confirmed.
This is the test that would have caught the Paradigm Peptides fraud — Mass Spectrometry would have immediately shown that the compounds in their vials (testosterone) had a completely different molecular weight than the labeled SARMs. Research from the NIH on analytical methods for peptide characterization confirms that ESI-MS combined with HPLC is the most reliable approach for verifying both compound identity and peptide purity simultaneously.
What to look for on a COA:
- Observed molecular weight: Should match the theoretical molecular weight for the target peptide
- Theoretical molecular weight: Should be listed for comparison
- Method: ESI-MS (Electrospray Ionization) or MALDI-TOF are the standard methods for identity verification alongside peptide purity analysis
How to Read a COA: Step by Step for Verifying Peptide Purity
When you receive a COA (or access one on a vendor’s website), check the following in order to properly assess compound integrity and peptide purity:
Step 1: Verify It Is Batch-Specific
The COA should include a lot number or batch number that corresponds to the specific product you received — not a generic report. If the COA shows results from six months ago with no batch identifier, it may not represent the actual quality of the product in your vial. Reputable vendors issue batch-specific COAs for every production run.
Step 2: Check for Both HPLC and Mass Spec
A complete COA includes both tests. HPLC alone (purity without identity confirmation) is incomplete. Mass Spectrometry alone (identity without purity data) is also insufficient. You need both tests to have full confidence in what you are working with as a researcher.
Step 3: Verify Purity ≥99%
Read the HPLC purity percentage directly on the COA. For research-grade compounds, expect 99%+ peptide purity. Be wary of vague claims like “high purity” without a specific number. Anything below 98% introduces meaningful impurity variables into experimental design that can compromise results.
Step 4: Confirm Molecular Weight Match
Compare the observed molecular weight (from Mass Spectrometry) to the expected molecular weight for the target compound. They should match within ±1-2 Da. A discrepancy of more than 2 Da suggests the material may not be what is labeled, regardless of the measured purity percentage.
Step 5: Check the Testing Methodology
The most credible COAs come from reputable, accredited analytical laboratories operating under ISO 17025 or equivalent quality frameworks — not from the vendor’s own internal testing alone. In-house testing without accredited verification creates a conflict of interest. Credible COAs document the analytical method in enough detail that the test could be reproduced, and they disclose the accreditation standard under which the lab operates. The FDA’s cGMP guidelines similarly require objective quality verification — applying this standard to research peptide procurement is simply good scientific practice. PSPeptides publishes every batch certification at pspeptides.com/certifications/, accessible to any researcher without an account or email request.
What Published Research Says About Purity and Experimental Outcomes
The scientific literature consistently demonstrates that peptide purity directly affects experimental reliability. Researchers studying the relationship between analytical grade and research reproducibility have identified compound quality as a key variable in the replication crisis affecting biomedical research.
A 2019 analysis published in Analytical Chemistry examined 200 commercially available research compounds and found that approximately 28% failed to meet their labeled peptide purity specifications when independently tested. Among samples claiming 95% purity, measured values ranged from 78% to 99.2% — a range that would produce dramatically different results in receptor binding assays. The study recommended that researchers independently verify compound quality before initiating any study.
Additional research from the European Journal of Pharmaceutical Sciences demonstrated that impurities at even 1-2% can significantly alter pharmacokinetic parameters in preclinical models, particularly for peptides with high receptor affinity. This reinforces why the 99%+ peptide purity threshold is not arbitrary — it represents the level at which impurity contributions become statistically negligible in most experimental contexts.
For researchers using compounds like BPC-157, GHK-Cu, or TB-500, high peptide purity is particularly important because these compounds interact with multiple biological pathways simultaneously — contaminants can confound which pathway is actually being studied.
Red Flags in COA Documentation
- No batch/lot number — the COA may not correspond to your specific product or its actual peptide purity level
- HPLC only, no Mass Spectrometry — purity is partially verified but identity is not confirmed
- In-house testing with no accreditation referenced — no objective verification; vendor is self-certifying their own quality claims
- COAs “available upon request” — if a vendor is confident in quality, they publish proactively
- Purity below 98% — not research-grade; significant impurity burden that compromises experimental data
- Generic or template-looking documents — professional COAs include specific instrument details, analyst signatures, and test dates
- Molecular weight does not match — the compound may not be what is labeled, regardless of any peptide purity percentage shown
- No method details — a COA without column type, mobile phase, or wavelength cannot be independently reproduced
Peptide Purity vs. Related Quality Metrics
Understanding peptide purity requires distinguishing it from related but distinct quality parameters. Researchers should be aware of how this metric interacts with others when evaluating COA documentation.
| Metric | What It Measures | Test Method |
|---|---|---|
| Peptide Purity | % of sample that is the target compound | HPLC |
| Identity Confirmation | Whether the compound is actually the labeled peptide | Mass Spectrometry |
| Sterility | Absence of bacterial contamination | Microbial testing |
| Endotoxin Level | Bacterial lipopolysaccharide content | LAL test |
For most research applications, peptide purity (HPLC) and identity (MS) are the two most critical parameters. Sterility and endotoxin testing become additionally important for injectable research applications. See our peptide reconstitution guide for information on maintaining quality after receipt, and our guide on peptide storage for best practices on preserving compound integrity.
How Storage Conditions Affect Peptide Purity After Receipt
Even a compound with verified 99%+ peptide purity can degrade if stored improperly. Maintaining quality after receipt requires following established protocols based on the compound’s specific properties.
Lyophilized (freeze-dried) peptides retain their purity best when stored at -20°C in a desiccated environment, away from repeated freeze-thaw cycles. Once reconstituted in bacteriostatic water or another appropriate solvent, the compound begins to degrade at a rate that depends on the amino acid composition, pH of the solution, and storage temperature. Most reconstituted research peptides should be used within 4-6 weeks when stored at 4°C, or aliquoted and stored at -20°C for longer periods to maintain acceptable peptide purity levels.
PSPeptides Testing Standards
Every PSPeptides product undergoes rigorous analytical testing via both HPLC and Mass Spectrometry before release. All results confirm 99%+ peptide purity before any product ships. Our COAs are batch-specific, publicly accessible on our Certifications page, and include full method details for reproducibility. PSPeptides has served more than 2,500 American researchers with this documentation standard applied consistently across every shipment.
View Our Certificates of Analysis → | Browse Products →
For more background on choosing a supplier that meets rigorous quality standards, see our guide on how to choose a research peptide supplier.
Frequently Asked Questions About Peptide Purity
What does 99% peptide purity actually mean?
A reading of 99% peptide purity means that 99% of the material in the vial is the target compound, and 1% consists of synthesis byproducts, degradation products, truncated sequences, or residual solvents. This is the minimum threshold considered research grade because impurities below 1% are statistically negligible in most experimental designs. Anything below 98% introduces enough impurity mass to potentially affect dose-response relationships and experimental outcomes.
Can I trust a COA from the same company that made the peptide?
In-house COAs without accredited verification represent a significant conflict of interest — the vendor is grading their own product. Testing conducted under ISO 17025 or equivalent accreditation provides objective data that cannot be influenced by commercial interests. Researchers should look for COAs that disclose the analytical methodology in full, including column, mobile phase, detection wavelength, and mass spectrometry parameters, so that the results could in principle be reproduced. PSPeptides publishes every COA with this level of methodology detail at pspeptides.com/certifications/.
Why do some vendors claim high purity without Mass Spectrometry?
HPLC alone can confirm a purity percentage but cannot confirm the compound’s identity. A sample could test at 99% on HPLC and still be the wrong compound entirely — chromatography would not detect this. Mass Spectrometry is essential because it confirms the molecular weight matches the target peptide. The Paradigm Peptides case demonstrated exactly this failure: their products showed high chromatographic purity, but the compound was not what was labeled on the vial.
How does peptide purity affect research reproducibility?
Research reproducibility is directly tied to compound quality consistency. If two researchers use peptides from different batches with different actual purity levels (even if both are labeled as 99%), their results may diverge significantly. Published research standards increasingly require documentation of peptide purity as part of methodology sections. Using verified 99%+ compounds from batch-specific COAs provides a documented quality baseline that supports reproducible, publishable results.
All products are intended for laboratory research use only. Not for human consumption.
PSPeptides — US Made & Shipped | Third-Party Tested | 99%+ Purity | Same-Day Shipping
All PSPeptides products are sold exclusively for research and laboratory use.